Brought to you by 
Janssen Biotech partners with Nodality
17 Apr 2014
Executive Summary
Nodality Inc. (cancer and immune disorder therapeutics) agreed to apply its Single Cell Network Profiling (SCNP) platform to Johnson & Johnson’s Janssen Biotech Inc.’s immunology programs.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Janssen Biotech partners with Nodality
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice